跳至主要内容
临床试验/ACTRN12609000138280
ACTRN12609000138280已完成4 期

A randomised controlled trial to evaluate the effect of unsupervised buprenorphine-naloxone on heroin use in heroin addicts compared to heroin use in addicts who remain on the wait-list to receive opiate-substitution therapy.

Hunter New England Area Health Service, Drug and Alcohol Clinical Services0 个研究点目标入组 50 人开始时间: 2009年3月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnostic and Statistical manual of Mental Disorders, Fourth Edition (DSM IV) diagnosis of heroin dependence disorder.
  • Recent heroin use (at least 20 days in the last month.
  • Stable accomodation within the local geographical area.
  • If female, willing to use contraception during the trial.

排除标准

  • Current pregnancy or breat feeding.
  • Children under 16 years at home with current Department of Community Services(DOCS) involvement.
  • Pending court hearings with a risk of custodial sentence.
  • Current DSMIV substance dependence to alcohol, benzodiazepines, amphetamines or cocaine.
  • Any Opiate Substitution Thearpy (OST) in the previous 4 weeks or more than 2 weeks consecutive OST in the previous 12 weeks.
  • Co-existing major medical or psychiatiric condistions where immediate OST and / or otehr treaments are warranted.

研究者

发起方
Hunter New England Area Health Service, Drug and Alcohol Clinical Services

相似试验